睾丸组织冷冻保存:学术中心协调网络8年经验
该研究描述了2011年1月至2018年11月期间通过协调网络对189例患者进行睾丸组织冷冻保存的经验,采用集中处理和冷冻的标准化方案。平均年龄7.9岁(标准差5岁),范围5个月至34岁,恶性肿瘤是最常见指征(n=118)。在137例分析中,132例确认存在生殖细胞。
要点
- 集中处理和冷冻多中心睾丸组织可行,可加速招募。
- 恶性肿瘤(n=118)是睾丸组织冷冻最常见指征。
- 137例分析中132例确认存在生殖细胞。
核心结论
- 集中处理和冷冻来自多个中心的睾丸组织是可行的,并能加速招募,提供统计效力以做出可能指导生育力保存实践的推断。
研究设计与样本
- 研究描述了2011年1月至2018年11月期间从189例患者冷冻保存的睾丸组织样本,记录医学诊断、既往化疗暴露、组织重量和生殖细胞存在情况。
主要发现
- 生育力保存患者平均年龄为7.9岁(标准差=5岁),范围5个月至34岁。
- 收集组织的平均量为411.3 mg(标准差=837.3 mg),范围14.4 mg至6880.2 mg。
- 恶性肿瘤(n=118)是最常见的睾丸组织冷冻指征,其次是血液疾病(n=45)和其他情况(n=26)。
- 39%(n=74)的患者在进行睾丸活检前已开始化疗。
- 在189例招募患者中,137例分析了生殖细胞存在情况,其中132例确认存在生殖细胞。
临床怎么用
- 当无其他选择时,患者和/或监护人愿意接受实验性生育力保存程序。
- 作者所在协调网络发现,许多患者在开始性腺毒性治疗后请求生育力保存。
- 作者认为,未分化的精原干细胞和祖细胞可能从处于治疗早期且尚未接受消融剂量治疗的患者睾丸组织中回收,但这些精原细胞的功能未测试。
局限性
- 这是一项描述性研究,睾丸组织来自有不育风险的患者。
- 由于样本量有限,这些活检中精原细胞的功能无法通过移植测试。
- 精原细胞的功能未测试。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is it feasible to disseminate testicular tissue cryopreservation with a standardized protocol through a coordinated network of centers and provide centralized processing/freezing for centers that do not have those capabilities? SUMMARY ANSWER: Centralized processing and freezing of testicular tissue from multiple sites is feasible and accelerates recruitment, providing the statistical power to make inferences that may inform fertility preservation practice. WHAT IS KNOWN ALREADY: Several centers in the USA and abroad are preserving testicular biopsies for patients who cannot preserve sperm in anticipation that cell- or tissue-based therapies can be used in the future to generate sperm and offspring. STUDY DESIGN, SIZE, DURATION: Testicular tissue samples from 189 patients were cryopreserved between January 2011 and November 2018. Medical diagnosis, previous chemotherapy exposure, tissue weight, and presence of germ cells were recorded. PARTICIPANTS/MATERIALS, SETTING, METHODS: Human testicular tissue samples were obtained from patients undergoing treatments likely to cause infertility. Twenty five percent of the patient's tissue was donated to research and 75% was stored for patient's future use. The tissue was weighed, and research tissue was fixed for histological analysis with Periodic acid-Schiff hematoxylin staining and/or immunofluorescence staining for DEAD-box helicase 4, and/or undifferentiated embryonic cell transcription factor 1. MAIN RESULTS AND THE ROLE OF CHANCE: The average age of fertility preservation patients was 7.9 (SD = 5) years and ranged from 5 months to 34 years. The average amount of tissue collected was 411.3 (SD = 837.3) mg and ranged from 14.4 mg-6880.2 mg. Malignancies (n = 118) were the most common indication for testicular tissue freezing, followed by blood disorders (n = 45) and other conditions (n = 26). Thirty nine percent (n = 74) of patients had initiated their chemotherapy prior to undergoing testicular biopsy. Of the 189 patients recruited to date, 137 have been analyzed for the presence of germ cells and germ cells were confirmed in 132. LIMITATIONS, REASONS FOR CAUTION: This is a descriptive study of testicular tissues obtained from patients who were at risk of infertility. The function of spermatogonia in those biopsies could not be tested by transplantation due limited sample size. WIDER IMPLICATIONS OF THE FINDINGS: Patients and/or guardians are willing to pursue an experimental fertility preservation procedure when no alternatives are available. Our coordinated network of centers found that many patients request fertility preservation after initiating gonadotoxic therapies. This study demonstrates that undifferentiated stem and progenitor spermatogonia may be recovered from the testicular tissues of patients who are in the early stages of their treatment and have not yet received an ablative dose of therapy. The function of those spermatogonia was not tested. STUDY FUNDING/COMPETING INTEREST(S): Support for the research was from the Eunice Kennedy Shriver National Institute for Child Health and Human Development grants HD061289 and HD092084, the Scaife Foundation, the Richard King Mellon Foundation, the Departments of Ob/Gyn & Reproductive Sciences and Urology of the University of Pittsburgh Medical Center, United States-Israel Binational Science Foundation (BSF), and the Kahn Foundation. The authors declare that they do not have competing financial interests.
引用
- Valli-Pulaski H, Peters KA, Gassei K, et al. Testicular tissue cryopreservation: 8 years of experience from a coordinated network of academic centers. Hum Reprod. 2019. PMID: 31111889. doi:10.1093/humrep/dez043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。